Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 100% increase over the number of companies cited in the previous year.
Of the 44 citations issued, the most common citations include:
- You did not collect and hold reserve samples of packaged and labeled dietary supplements that you distributed.
- You did not establish and follow written procedures for holding and distributing operations.
- You did not establish and follow written procedures for when a returned dietary supplement is received.
Most of the companies cited were involved in either Food and Cosmetics or Biologics sectors. The second most common type of company cited in the time period worked in the the Devices sector.
All of the companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
American Red Cross Blood Services | Biologics | 10/16/2023 | Backup data not assured as exact and complete |
AmerisourceBergen Drug Corporation | Food and Cosmetics | 06/15/2023 | Reserve sample - collect, hold |
AmerisourceBergen Drug Corporation | Food and Cosmetics | 06/15/2023 | Quality control operations - returned dietary supplement |
AmerisourceBergen Drug Corporation | Food and Cosmetics | 06/15/2023 | Written procedures - holding |
AmerisourceBergen Drug Corporation | Food and Cosmetics | 06/15/2023 | Written procedures - returned dietary supplement |
Avioq, Inc. | Biologics | 12/05/2023 | Identification procedures, Lack of or inadequate procedures |
Avioq, Inc. | Biologics | 12/05/2023 | Lack of or inadequate procedures for storage. |
Avioq, Inc. | Biologics | 12/05/2023 | DHR - not or inadequately maintained |
Biogen U. S. Corporation | Biologics | 10/17/2023 | Control procedures to monitor and validate performance |
Biogen U. S. Corporation | Biologics | 10/17/2023 | Procedures for sterile drug products |
Biogen U. S. Corporation | Biologics | 10/17/2023 | Scientifically sound laboratory controls |
Biogen U. S. Corporation | Biologics | 10/17/2023 | Investigations of discrepancies, failures |
Biogen U. S. Corporation | Biologics | 10/17/2023 | Procedures to be written and followed |
Carolina Conceptions, PA | Biologics | 06/01/2023 | Determination based on screening and testing |
Carolina Conceptions, PA | Biologics | 06/01/2023 | Labeled re: biohazard, risks, test results |
CivaTech Oncology, Inc. | Devices | 06/14/2023 | Design input - documentation |
CivaTech Oncology, Inc. | Devices | 06/14/2023 | Design Validation - Risk analysis not performed/inadequate |
CivaTech Oncology, Inc. | Devices | 06/14/2023 | Lack of or inadequate final acceptance procedures |
CivaTech Oncology, Inc. | Devices | 06/14/2023 | DHR - not or inadequately maintained |
Concept Food Services Distributors, Inc. | Food and Cosmetics | 08/03/2023 | Hazard analysis biological, chemical, physical |
Concept Food Services Distributors, Inc. | Food and Cosmetics | 08/03/2023 | Approved supplier procedures - importer established |
GlacierPoint Enterprises - Carolinas | Food and Cosmetics | 07/20/2023 | Grounds |
GlacierPoint Enterprises - Carolinas | Food and Cosmetics | 07/20/2023 | Sanitary operations - Plant maintenance |
GlacierPoint Enterprises - Carolinas | Food and Cosmetics | 07/20/2023 | Plant operations - Precautions |
GlacierPoint Enterprises - Carolinas | Food and Cosmetics | 07/20/2023 | Storage and Distribution |
Luminelle, Inc. | Devices | 02/21/2023 | Individual Report of Malfunction |
Luminelle, Inc. | Devices | 02/21/2023 | Management review - defined interval, sufficient frequency |
Luminelle, Inc. | Devices | 02/21/2023 | Training records |
Luminelle, Inc. | Devices | 02/21/2023 | Design verification - Lack of or inadequate procedures |
Luminelle, Inc. | Devices | 02/21/2023 | Design Validation - Risk analysis not performed/inadequate |
Luminelle, Inc. | Devices | 02/21/2023 | Evaluation of suppliers, contractors, etc., requirements |
Luminelle, Inc. | Devices | 02/21/2023 | Lack of or inadequate complaint procedures |
North Carolina Center for Reproductive Medicine, Inc. | Biologics | 01/26/2023 | Determination based on screening and testing |
North Lily Foods, Inc. | Food and Cosmetics | 10/23/2023 | Definition very small importer |
SpringWorks Therapeutics, Inc. | Drugs | 03/31/2023 | General responsibilities of sponsors |
Sweetbottoms Naturals, LLC | Food and Cosmetics | 11/08/2023 | Specifications - labels, packaging |
Sweetbottoms Naturals, LLC | Food and Cosmetics | 11/08/2023 | Reserve sample - collect, hold |
Sweetbottoms Naturals, LLC | Food and Cosmetics | 11/08/2023 | Written procedures - quality control operations |
Sweetbottoms Naturals, LLC | Food and Cosmetics | 11/08/2023 | Written procedures - holding |
Sweetbottoms Naturals, LLC | Food and Cosmetics | 11/08/2023 | Written procedures - returned dietary supplement |
Sweetbottoms Naturals, LLC | Food and Cosmetics | 11/08/2023 | Written procedures - product complaint |
WatchChild, LLC | Devices | 12/13/2023 | Lack of or inadequate procedures |
WatchChild, LLC | Devices | 12/13/2023 | Lack of or inadequate complaint procedures |
WatchChild, LLC | Devices | 12/13/2023 | Statistical techniques - Lack of or inadequate procedures |